Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial

INTRODUCTION: Patients with type 2 diabetes are at risk of microvascular and macrovascular complications. Intensive glycaemic control, especially in patients with short duration of diabetes, is the mainstay of management of type 2 diabetes to lower the risk of complications. However, despite the imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nam Hoon, Lim, Soo, Kwak, Soo Heon, Moon, Min Kyong, Moon, Jun Sung, Lee, Yong-ho, Cho, Ho Chan, Lee, Juneyoung, Kim, Sin Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157558/
https://www.ncbi.nlm.nih.gov/pubmed/30249630
http://dx.doi.org/10.1136/bmjopen-2018-022448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157558/
https://www.ncbi.nlm.nih.gov/pubmed/30249630
http://dx.doi.org/10.1136/bmjopen-2018-022448

Ejemplares similares